MTOR and pancreatic neuroendocrine neoplasm: Studies have shown that in pancreatic neuroendocrine neoplasms, FABP5 activates the PI3K/Akt/mTOR signalling pathway, leading to enhanced lipid metabolism and cellular proliferation [41].